KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program
暂无分享，去创建一个
P. Jares | C. Langner | P. Quirke | S. Tejpar | F. Bosman | M. Ligtenberg | R. Seruca | G. Bevilacqua | A. Ensari | T. Kirchner | A. Jung | F. Carneiro | J. Fléjou | T. P. Hansen | G. Hertogh | D. Tiniakos | G. Hoefler | J. Krieken | F. Carneiro | J. V. Krieken | T. Plato Hansen